You have 9 free searches left this month | for more free features.

Solid and hematologic malignant tumors

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tissue Specimens From Solid Tumors or Blood Disorders and Their

Recruiting
  • Neoplasms
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    CIBMTR Research Database

    Recruiting
    • Autologous Stem Cell Transplantation
    • +6 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 20, 2023

      Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

      Not yet recruiting
      • Advanced Malignant Solid Tumors
      • Neoantigen mRNA Personalised Cancer vaccine
      • (no location specified)
      Jul 16, 2023

      Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

      Not yet recruiting
      • Mesothelin-positive Advanced Malignant Solid Tumors
      • Anti-mesothelin CAR-T cells
      • (no location specified)
      Mar 13, 2023

      Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

      Not yet recruiting
      • Advanced Solid Tumor
      • +4 more
      • Peking, Beijing, China
        Department of radiation oncology, Peking University Third Hospit
      Jun 20, 2023

      Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

      Not yet recruiting
      • Cutaneous Tumor
      • Malignant Solid Tumor
      • JCXH-211 Injection
      • (no location specified)
      Feb 13, 2023

      Malignant Tumors Trial (IMMH-010)

      Enrolling by invitation
      • Malignant Neoplasms
      • Guangzhou, China
        Guangdong Provincial People's Hospital
      Dec 30, 2022

      Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

      Recruiting
      • Mesothelin-positive Advanced Malignant Solid Tumors
      • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital Zhejiang University School of Medi
      May 11, 2023

      Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)

      Not yet recruiting
      • Advanced Malignant Solid Tumors
      • Shanghai, Shanghai, China
        Zhongshan Hospital Fudan University
      May 23, 2023

      Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

      Not yet recruiting
      • Advanced Malignant Solid Tumors
      • Neoantigen peptide vaccine
      • Neoantigen-based DC immune preparation
      • Nanchang, Jiangxi, China
        First Affiliated Hospital of Nanchang University
      Mar 1, 2023

      Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

      Not yet recruiting
      • Carcinoma
      • Solid Tumor
      • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
      • Suzhou, China
        Second Affiliated Hospital of Soochow University
      Oct 26, 2023

      Solid Tumor Trial (UCLM802 Cell Injection)

      Not yet recruiting
      • Solid Tumor
      • UCLM802 Cell Injection
      • (no location specified)
      Mar 7, 2023

      Malignant Solid Tumors Trial (2.5-3.5mCi 64Cu-FAPI-XT117, 3.5-4.5mCi 64Cu-FAPI-XT117, 4.5-5.5mCi 64Cu-FAPI-XT117)

      Not yet recruiting
      • Malignant Solid Tumors
      • 2.5-3.5mCi 64Cu-FAPI-XT117
      • +2 more
      • (no location specified)
      Jul 7, 2023

      Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

      Not yet recruiting
      • Malignant Solid Tumor
      • GEN1042
      • +4 more
      • (no location specified)
      Sep 21, 2023

      Advanced Malignant Solid Tumors Trial in Shanghai (CM082)

      Active, not recruiting
      • Advanced Malignant Solid Tumors
      • Shanghai, Shanghai, China
        Shanghai East Hospital
      Nov 10, 2022

      Advanced Malignant Solid Tumors Trial in Beijing (9MW2821)

      Recruiting
      • Advanced Malignant Solid Tumors
      • Beijing, Beijing, China
      • +1 more
      Mar 6, 2023

      Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)

      Not yet recruiting
      • Recurrent or Metastatic Solid Tumors
      • Recombinant Anti-EpCAM-CD3 Antibody Injection
      • (no location specified)
      Oct 17, 2023

      Advanced Malignant Solid Tumors Trial (JCXH-212 Injection)

      Not yet recruiting
      • Advanced Malignant Solid Tumors
      • JCXH-212 Injection
      • (no location specified)
      Oct 11, 2022

      Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

      Not yet recruiting
      • Solid Tumor, Adult
      • +4 more
      • (no location specified)
      Apr 24, 2023

      Advanced Solid Tumors Trial in Guangzhou (JS109 combine with irinotecan)

      Recruiting
      • Advanced Solid Tumors
      • JS109 combine with irinotecan
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Apr 9, 2023

      Advanced Malignant Tumors Trial in Shanghai (IBB0979)

      Recruiting
      • Advanced Malignant Tumors
      • Shanghai, Shanghai, China
        Shanghai East Hospital
      Aug 7, 2023

      Advanced Solid Tumor Trial (SHR-4602 for injection)

      Not yet recruiting
      • Advanced Solid Tumor
      • SHR-4602 for injection
      • (no location specified)
      Apr 6, 2023

      Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)

      Not yet recruiting
      • Digestive System Malignant Solid Tumors
      • ScTIL injection
      • ScTIL injection and B lymphocytes adjuvant
      • (no location specified)
      Feb 7, 2023

      Advanced Malignant Tumor Trial (HRS-2189 Tablets)

      Not yet recruiting
      • Advanced Malignant Tumor
      • HRS-2189 Tablets
      • (no location specified)
      May 6, 2023

      Advanced Solid Tumors Trial in Jinan, Shanghai (PM1003 Injection)

      Recruiting
      • Advanced Solid Tumors
      • PM1003 Injection
      • Jinan, Shandong, China
      • +1 more
      May 8, 2023